| Title |
A Comprehensive and Observational Myeloproliferative
Neoplasms (MPN) Registry in the Province of Quebec |
| Protocole ID |
Registre NMP |
| ClinicalTrials.gov ID |
|
| Cancer Type(s) |
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
| Phase |
Other |
| Stage |
|
| Study Type |
|
| Drug |
|
| Institution |
CIUSSS DU NORD-DE-L'ILE-DE-MONTREAL
 HOPITAL DU SACRE-COEUR-DE-MONTREAL
5400 boul. Gouin Ouest, Montréal, QC, H4J1C5
|
| City |
Montréal |
| Principal Investigator |
Dr. Inès Chamakhi
|
| Coordinator |
Caroline Chagnon
514-338-2222 poste 2816
|
| Status |
Recruiting |
| Activation Date |
|
| Eligibility Criteria |
All patients who meet the following inclusion criteria may be enrolled in the MPN Registry:
- Have a diagnosis of PV, ET, or MF as defined by the World Health Organization (WHO) diagnostic criteria for myeloproliferative neoplasms [7];
- Are 18 years of age or older;
- Are able to give written, informed consent (or have a legal representative who can give written, informed consent when applicable).
|
| Exclusion Criteria |
Patients who meet any of the following criteria will be excluded from participation:
- Life expectancy of less than 3 months for a condition not related to MPN;
- Patients suffering of CML.
|
| |
|
Groupe d'étude en oncologie du Québec